LONALeonaBio, Inc.

$26M

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$23M

Net Income

-$21M

EPS (Diluted)

$-4.90

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$17M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$313M

Total Liabilities

$11M

Stockholders' Equity

$302M

Cash & Equivalents

$118M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$23M	-$11M	-116.9%
Net Income	-$21M	-$9M	-136.6%

LONA Q1 2022 Earnings — LeonaBio, Inc. Revenue & Financial Results | Market Cap Arena